MACROGENICS INC (MGNX) Form 8-K — Jul 8, 2026
On July 1, 2026, Karen Ferrante, M.D. notified the board of MacroGenics, Inc. of her decision to resign as a director, effective September 1, 2026. Dr.
Price after filing
1 day: -1.9%7 days: -7.3%30 days: -13.9%
Close on the filing date to close N calendar days later (from $4.66). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.